Indication
Substance Use Disorders
6 registered trials testing Psilocybin, Ketamine for this indication, none currently recruiting.
6
Registered trials
0
Recruiting
0
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 6 trials for Substance Use Disorders
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Ketamine for Methamphetamine Use DisorderNCT06496750 · University of Texas Southwestern Medical Center | Active, not recruiting | Phase 2 | ketamine | 5 |
| Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderNCT07499583 · Indiana University | Not yet recruiting | Phase 1 / Phase 2 | psilocybin | 2 |
| Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use DisorderNCT05322954 · University of Wisconsin, Madison | Terminated | Phase 1 | psilocybin | 1 |
| Substance Misuse To Psychosis for Ketamine (SToP-K)NCT03485339 · The University of Hong Kong | Completed | N/A | ketamine | 2 |
| Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men PopulationNCT03753737 · Hospices Civils de Lyon | Completed | N/A | ketamine | 1 |
| Effectiveness of a Brief Cognitive and Behavioral Skills Program on Stage Transitions for Chronic Ketamine AbusersNCT03644719 · National Taiwan University | Completed | Not applicable | ketamine | — |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.